Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
87pct
27d open
vs 5,674 other S bills in the 119th — cohort avg 32d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (5)
2026 · third_quarter · Defense
Star Print ordered on the bill.
Read twice and referred to the Committee on Armed Services.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
TRICARE Pharmacy Network Oversight & Changes; H.R.8800/S.4784, the National Defense Authorization Act for Fiscal Year 2027; H.R. 6400/S.4106,the RxACCESS Act; Veterans Affairs Health Pharmacy Program;
Client expense: $370,000 · Firm income: Not reported
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Pharmacy
H.R. 2484 Seniors Access to Critical Medications Act H.R. 2853 Combating Organized Retail Crime Act H.R. 3164 Ensuring Community Access to Pharmacist Services Act H.R. 4317 PBM Reform Act S. 526 Pharmacy Benefit Manager (PBM) Transparency Act S. 527 Prescription Pricing for the People Act S. 882 Patients Before Middlemen (PBM) Act S. 927 Protecting Pharmacies in Medicaid Act S. 1404 Combating Organized Retail Crime Act S. 2426 Equitable Community Access to Pharmacist Services Act S. 3345 PBM Price Transparency and Accountability Act H.R. 6609 Pharmacists Fight Back in Medicare and Medicaid Act H.R. 6575 CommonGround for Affordable Health Care Act H.R. 6501 Bipartisan Health Insurance Affordability Act H.R. 5256 340B ACCESS Act H.R. 4581 340B PATIENTS Act S. 2372 340B PATIENTS Act H.R. 6400 Rx ACCESS Act S. 4106 Rx ACCESS Act S. 3788 CLEAR LABELS Act S. 4509 Patients Before Monopolies Act H.R. 8779 Patients Before Monopolies Act S. 3822 Break Up Big Medicine Act H.R. 8800 National Defense Authorization Act S. 4784 National Defense Authorization Act S. 3097 Health Information Privacy Reform Act
Client expense: $480,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Veterans
Discussions regarding veteran and military spouse programs Discussions in support of H.R.6400/S.4106, RX Access Act
Client expense: $1,890,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Veterans
Discussions regarding veteran and military spouse programs Discussions in support of H.R.6400/S.4106, RX Access Act
Client expense: $2,060,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Pharmacy
H.R. 2484 Seniors Access to Critical Medications Act H.R. 2853 Combating Organized Retail Crime Act H.R. 3164 Ensuring Community Access to Pharmacist Services Act H.R. 4317 PBM Reform Act S. 526 Pharmacy Benefit Manager (PBM) Transparency Act S. 527 Prescription Pricing for the People Act S. 882 Patients Before Middlemen (PBM) Act S. 927 Protecting Pharmacies in Medicaid Act S. 1404 Combating Organized Retail Crime Act S. 2426 Equitable Community Access to Pharmacist Services Act S. 3345 PBM Price Transparency and Accountability Act H.R. 6609 Pharmacists Fight Back in Medicare and Medicaid Act H.R. 6575 CommonGround for Affordable Health Care Act H.R. 6501 Bipartisan Health Insurance Affordability Act H.R. 5256 340B ACCESS Act H.R. 4581 340B PATIENTS Act S. 2372 340B PATIENTS Act H.R. 6400 Rx ACCESS Act S. 4106 Rx ACCESS Act S. 3788 CLEAR LABELS Act S. 4509 Patients Before Monopolies Act H.R. 8779 Patients Before Monopolies Act S. 3822 Break Up Big Medicine Act H.R. 8800 National Defense Authorization Act S. 4784 National Defense Authorization Act
Client expense: $290,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Pharmacy
H.R.6400/S.4106 - Rx ACCESS Act; H.R.3164/S.2426 - Equitable Community Access to Pharmacist Services Act
Client expense: $350,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Defense
TRICARE Pharmacy Network Oversight & Changes; H.R.8800/S.4784, the National Defense Authorization Act for Fiscal Year 2027; H.R. 6400/S.4106,the RxACCESS Act;
Client expense: $270,000 · Firm income: Not reported
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Health Issues
H.R. 1613, S. 1038 - Drug Price Transparency in Medicaid Act, including issues related to PBM Spread Pricing; S. 260, H.R. 704 - Promoting Access to Diabetic Shoes Act; H.R. 1770 - Equitable Community Access to Pharmacist Services Act; S. 127 - Pharmacy Benefit Manager Transparency Act; Issues related to Food as Medicine initiatives and pharmacy scope of practice; S. 1339 - Pharmacy Benefit Manager Reform Act; S. 2052 - Protect Patient Access to Pharmacies Act; H.R. 5378 - The Lower Costs, More Transparency Act; H.R. 2484 - Seniors Access to Critical Medications Act; S. 575 / H.R. 1317 - Improving Care and Access to Nurses Act; H.R. 3164/S. 2426, the Equitable Community Access to Pharmacist Services Act; H.R. 7148, the Consolidated Appropriations Act, 2026; H.R.6199/S.3934, Medical Nutrition Therapy Act of 2025; H.R. 2484, the Seniors' Access to Critical Medications Act; H.R. 7567, The Farm, Food, and National Security Act; H.R. 2853 / S. 1404, Combating Organized Retail Crime Act; H.R. 6609, the Pharmacists Fight Back Act; S. 3822, the Break Up Big Medicine Act; H.R. 6400 / S. 4106, the Rx ACCESS Act; issues related to pharmacy scope of practice, the Rural Health Transformation Fund and medical nutrition therapy; issues related to Medicare drug pricing, MTF program; issues related to at-home drug disposal; issues related to PBM reform.
Client expense: $400,000 · Firm income: Not reported
2026 · first_quarter · Veterans
Discussions regarding veteran and military spouse programs. Discussions in support of H.R.6400/S.4106, RX Access Act
Client expense: $3,290,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Defense
H.R. 3838/S2296 Pharmacy issues related to the National Defense Authorization Act, FY2026 HR. 6400 / S. 4106 - Rx Access, Choice, Cost Equity, and Supply Stability (Rx ACCESS) Act
Client expense: $3,490,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Pharmacy
H.R. 7148 Consolidated Appropriations Act, 2026 H.R. 2484 Seniors Access to Critical Medications Act H.R. 2853 Combating Organized Retail Crime Act H.R. 3164 Ensuring Community Access to Pharmacist Services Act H.R. 4317 PBM Reform Act S. 526 Pharmacy Benefit Manager (PBM) Transparency Act S. 527 Prescription Pricing for the People Act S. 882 Patients Before Middlemen (PBM) Act S. 927 Protecting Pharmacies in Medicaid Act S. 1404 Combating Organized Retail Crime Act S. 2426 Equitable Community Access to Pharmacist Services Act S. 3345 PBM Price Transparency and Accountability Act H.R. 6609 Pharmacists Fight Back in Medicare and Medicaid Act H.R. 6575 CommonGround for Affordable Health Care Act H.R. 6501 Bipartisan Health Insurance Affordability Act H.R. 5256 340B ACCESS Act H.R. 4581 340B PATIENTS Act S. 2372 340B PATIENTS Act H.R. 6400 Rx ACCESS Act S. 4106 Rx ACCESS Act S. 3788 CLEAR LABELS Act
Client expense: $320,000 · Firm income: Not reported
2026 · first_quarter · Defense
TRICARE Pharmacy Network Oversight & Changes; National Defense Authorization Act for Fiscal Year 2026; H.R. 6400/S.4106,the RxACCESS Act;
Client expense: $320,000 · Firm income: Not reported
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
| Republican |
| WV |
| Tim Kaine | Democratic | VA |
Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Office of Policy Development, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE